The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in colon cancer cells
V. Slaninova, L. Heron-Milhavet, M. Robin, L. Jeanson, D. Kantar, D. Tosi, L. Berhelin, C. Gongora, A. Djiane
The paper shows that TAZ/WWTR1 promotes oxaliplatin sensitivity in colon cancer cells through nuclear accumulation, independent of P73 but requiring DNA damage and P53 activity.
bioRxiv · Mar 17, 2023 · PreprintCancer Biology